Article Text
Original Articles
DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer
Abstract
Nuclear DNA content and p53 immunoreactivity were determined in 53 cases of primary fallopian tube cancer (PFTC). All tumors showed a distinctly aneuploid DNA distribution pattern, whereas p53 immunoreactivity was observed in 51% of the cases. If the patients were divided into two groups according to survival time, p53 immunoreactivity was present in 40% of the tumors from patients surviving for more than 8 years and in 65% of tumors from patients who died within 2 years. This difference was not statistically significant (P = 0.438). Patient survival was significantly correlated to the clinical stage (FIGO) (P = 0.0009).
- p53
- ploidy
- primary fallopian tube cancer
- staging
Statistics from Altmetric.com
Footnotes
This study was supported by the Cancer Society in Stockholm.